The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
Subscribe To Our Newsletter & Stay Updated
